VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
Status:
Recruiting
Trial end date:
2022-03-19
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy of VERU-111 in the treatment of SARS-Cov-2 Infection by assessing
its effect on the proportion of patients who die on study (prior to Day 60).